ZFP36L1 Enhances Microglial Ferroptosis in Ischemic Stroke by Reducing FTO‐Mediated N6‐Methyladenosine Demethylation of ACSL1 mRNA
- 1Department of Neurology The First Hospital of Hebei Medical University Shijiazhuang Hebei Province People's Republic of China
- 2Department of Neurology The First Affiliated Hospital of Hebei North University Zhangjiakou Hebei Province People's Republic of China
Abstract
Microglia play an important role in ischemic stroke (IS). However, the molecular regulatory mechanisms underlying microglial ferroptosis in IS remain incompletely understood. In this study, blood samples were collected from 20 IS patients and 15 healthy volunteers. Microglia BV‐2 subjected to oxygen–glucose deprivation/reoxygenation (OGD/R) and mice undergoing middle cerebral artery occlusion‐reperfusion (MCAO/R) surgery were used to establish IS models. Our results revealed that in blood samples from IS patients and in OGD/R‐treated BV‐2 cells, ZFP36 ring finger protein like 1 (ZFP36L1) and Acyl‐CoA synthetase long chain family member 1 (ACSL1) expression was increased, while the fat mass and obesity‐associated (FTO) protein expression was decreased. ACSL1 silencing attenuated ferroptosis and inflammation in OGD/R‐treated microglia, as evidenced by decreased levels of malondialdehyde, Fe2+, lipid peroxidation, inflammatory factors, along with an increased Glutathione/Glutathione disulfide ratio. Additionally, ZFP36L1 silencing suppressed the OGD/R‐induced promotion of ferroptosis and inflammation in microglia and alleviated cerebral ischemic injury in MCAO/R mice, whereas ACSL1 overexpression reversed these alterations caused by ZFP36L1 silencing. Mechanistically, ZFP36L1 decreased FTO messenger RNA (mRNA) stability and reduced FTO expression. FTO overexpression reduced ACSL1 N6‐methyladenosine (m6A) modification and ACSL1 expression. In conclusion, ZFP36L1 increased ACSL1 m6A modification and ACSL1 expression to promote microglial ferroptosis, neuroinflammatory response, and cerebral ischemic injury in IS by reducing FTO mRNA stability.
Related
- Sustaining microglial reparative function enhances stroke recovery
- Extracellular CIRP Dysregulates Microglial Efferocytosis in Acute Ischemic Stroke via the TLR4/miR‐155/MafB Axis
- From scavenger to victim: mechanism and treatment of microglial ferroptosis in white matter injury disease
- Knockdown of CLEC7A Alleviates Ischemic Brain Injury by an Anti-Inflammatory Microglial Phenotype via the CXCL1/CXCR2 Axis.
- The A-FABP Nexus in the Neurovascular Unit: Bridging Endothelial Barrier Breakdown and Microglial Lipotoxicity in Ischemic Stroke.
BibTeX
@article{song2026zfp36l1,
title = {{ZFP36L1 Enhances Microglial Ferroptosis in Ischemic Stroke by Reducing FTO‐Mediated N6‐Methyladenosine Demethylation of ACSL1 mRNA}},
author = {Ai‐Xia Song and Han‐Xu Jin and Yuan‐Xin Sun and Wen‐Hui Kou and Xiao‐Ning Niu and Huan‐Huan Wang and Ting‐Ting Zhong and Ping Gu},
journal = {Kaohsiung Journal of Medical Sciences},
year = {2026},
month = nov,
doi = {10.1002/kjm2.70212},
url = {https://doi.org/10.1002/kjm2.70212},
note = {CC BY},
}
RIS
TY - JOUR
TI - ZFP36L1 Enhances Microglial Ferroptosis in Ischemic Stroke by Reducing FTO‐Mediated N6‐Methyladenosine Demethylation of ACSL1 mRNA
AU - Ai‐Xia Song
AU - Han‐Xu Jin
AU - Yuan‐Xin Sun
AU - Wen‐Hui Kou
AU - Xiao‐Ning Niu
AU - Huan‐Huan Wang
AU - Ting‐Ting Zhong
AU - Ping Gu
PY - 2026
DA - 2026/11/06
JO - Kaohsiung Journal of Medical Sciences
DO - 10.1002/kjm2.70212
UR - https://doi.org/10.1002/kjm2.70212
AB - Microglia play an important role in ischemic stroke (IS). However, the molecular regulatory mechanisms underlying microglial ferroptosis in IS remain incompletely understood. In this study, blood samples were collected from 20 IS patients and 15 healthy volunteers. Microglia BV‐2 subjected to oxygen–glucose deprivation/reoxygenation (OGD/R) and mice undergoing middle cerebral artery occlusion‐reperfusion (MCAO/R) surgery were used to establish IS models. Our results revealed that in blood samples from IS patients and in OGD/R‐treated BV‐2 cells, ZFP36 ring finger protein like 1 (ZFP36L1) and Acyl‐CoA synthetase long chain family member 1 (ACSL1) expression was increased, while the fat mass and obesity‐associated (FTO) protein expression was decreased. ACSL1 silencing attenuated ferroptosis and inflammation in OGD/R‐treated microglia, as evidenced by decreased levels of malondialdehyde, Fe2+, lipid peroxidation, inflammatory factors, along with an increased Glutathione/Glutathione disulfide ratio. Additionally, ZFP36L1 silencing suppressed the OGD/R‐induced promotion of ferroptosis and inflammation in microglia and alleviated cerebral ischemic injury in MCAO/R mice, whereas ACSL1 overexpression reversed these alterations caused by ZFP36L1 silencing. Mechanistically, ZFP36L1 decreased FTO messenger RNA (mRNA) stability and reduced FTO expression. FTO overexpression reduced ACSL1 N6‐methyladenosine (m6A) modification and ACSL1 expression. In conclusion, ZFP36L1 increased ACSL1 m6A modification and ACSL1 expression to promote microglial ferroptosis, neuroinflammatory response, and cerebral ischemic injury in IS by reducing FTO mRNA stability.
SN - 2410-8650
SN - 1607-551X
ER -